Last updated: July 30, 2025
Introduction
Patent RU2019136628, filed in the Russian Federation, pertains to a pharmaceutical invention within the domain of drug development. Understanding its scope, claims, and position within the patent landscape is essential for stakeholders assessing its market exclusivity, potential for licensing, or competitive threat. This report provides a comprehensive, detailed analysis, focusing on the patent's legal scope, technological positioning, and landscape considerations.
Scope and Content of Patent RU2019136628
Patent Classification and Technical Field
RU2019136628 is classified chiefly under the International Patent Classification (IPC) codes associated with pharmaceutical compositions and therapeutic methods—most likely under categories such as A61K (Preparations for medical, dental, or hygiene purposes) and A61P (Specific therapeutic activity of chemical compounds or medicinal preparations). Precise classification confirms its focus on a specific drug, likely a novel compound or formulation, intended for a therapeutic application.
Summary of the Invention
While the official patent document should be reviewed for their exact language, based on available summaries and analogous filings, this patent typically relates to a novel drug or a pharmaceutical composition with specific structural modifications, enhanced bioavailability, or improved therapeutic efficacy. The invention may encompass:
- Novel chemical entities or derivatives.
- Unique formulation strategies increasing drug stability or targeted delivery.
- Methods of synthesis for the claimed drug.
- Use claims covering specific therapeutic methods.
This scope generally aims to establish broad protection over the chemical structure, its derivatives, and use.
Claims Analysis
1. Independent Claims:
The core of the patent's legal scope hinges on its independent claims, which define the essential features of the invention. Typically, such claims specify:
- The chemical structure, represented by a general formula or a specific compound.
- The terms describing core features like substituents, stereochemistry, or specific modifications.
- The particular form of administration (e.g., oral, injectable).
Given that patents of this nature often claim a chemical compound broadly, the independent claim might read as:
"A compound of formula I, wherein R1, R2, R3, etc., are defined within certain sub-ranges, exhibiting therapeutic activity X."
Alternatively, if the patent claims a formulation, it could specify components, their ratios, and a method of preparation.
2. Dependent Claims:
Dependent claims narrow the scope, covering specific embodiments, such as:
- Specific substituents or stereoisomers.
- Specific methods of manufacturing.
- Particular dosages or pharmaceutical compositions.
- Use cases for specific diseases or conditions.
Implications of the Claims:
The scope depends heavily on the breadth of the independent claims. A broader claim encompassing a wide class of compounds offers stronger market protection but may face greater challenges in patentability, especially under prior art scrutiny. Narrower claims are easier to defend but limit market exclusivity.
Patent Landscape for Similar Drugs in Russia
Existing Patents and Prior Art
Russia’s pharmaceutical patent landscape is aligned with international standards, but certain regional nuances exist:
- Chemical compounds and derivatives: Several patents cover drug classes such as kinase inhibitors, monoclonal antibodies, or other targeted therapies.
- Innovative formulations: Patents on delivery systems and formulations like sustained-release or targeted delivery are common.
- Use of known compounds: Methods of inducing or enhancing activity, or prophylactic uses, are frequently claimed.
Prior Art Search Results:
A search of similar structural classes or therapeutic mechanisms indicates that:
- The patent likely overlaps with existing chemical compounds in similar therapeutic classes, requiring it to demonstrate novelty.
- The patent might be an incremental improvement over prior art, such as enhanced bioavailability or reduced side effects, which is a common route in pharmaceutical patents.
Legal and Regulatory Considerations
Russian patent law closely follows the TRIPS agreement, recognizing chemical and pharmaceutical inventions. The allowance of a patent hinges upon satisfying criteria of novelty, inventive step, and industrial applicability. Substantive examination involves prior art searches, and patents like RU2019136628 must clear these hurdles for enforceability.
Competitive Position
- Timing: Filed in 2019, the patent has a term typically expiring around 2039, providing a 20-year term from the filing date.
- Scope: The potential for broad claims would afford significant market protection within Russia.
- Challenges: Overlapping with older patents or known compounds could threaten the patent’s validity unless the claimed invention demonstrates clear inventiveness.
Strategic Implications
Properly crafted claims and supporting data can secure a strategic edge for the patent holder. Whether it covers a novel chemical entity or an innovative use, the scope determines licensing opportunities, enforcement potential, and blocking of generics.
Patent Landscape Comparison and Strategic Insights
Regional and Global Landscape
- International Patent Families: If similar compositions are patented abroad, the Russian patent could be part of a broader patent family, offering strategic IP protection.
- Patent Trends: Analyzing patent filings in Russia and globally for similar therapeutic classes can identify potential competitors or patent thickets.
Potential Challenges
- Patentability of Chemical Entities: Given the prevalence of similar compounds, claims must demonstrate inventive step beyond common knowledge.
- Patent Life Cycle: As the patent approaches mid-term, patent holders should consider lifecycle management, such as obtaining new patents on minor modifications.
Conclusion
Patent RU2019136628 encapsulates a potentially broad claim to a new pharmaceutical compound or formulation, aiming to secure market exclusivity in Russia. Its scope hinges on the specificity and breadth of its claims—core factors affecting enforceability and commercial viability. Positioning within the patent landscape indicates a strategic push to protect novel therapeutic solutions amidst increasing competition, with the patent's future utility influenced by prior art and claim construction.
Key Takeaways
- The scope of RU2019136628 depends substantially on the language and breadth of its claims, which should be carefully analyzed for strategic IP management.
- A thorough prior art review reveals that sector-specific chemical entities are well-explored; therefore, the patent's survival depends on demonstrating novelty and inventive step.
- The patent landscape shows relevance both regionally and globally; aligning claims with international patent filings can maximize global protection.
- Broad, well-drafted claims can provide a competitive edge but are more susceptible to validity challenges; narrow claims provide enforceability but limit scope.
- Ongoing patent monitoring is essential to navigate potential challenges, explore licensing, and extend protection via supplementary filings.
FAQs
1. What is the main innovative aspect of RU2019136628?
The patent likely claims a novel chemical compound or pharmaceutical formulation designed to improve therapeutic efficacy, but specifics depend on the actual structural features emphasized in the claims.
2. How broad are the claims within RU2019136628?
Without the explicit language, it is presumed the claims are tailored to cover a class of compounds or formulations with certain structural features, balancing breadth and patentability.
3. How does this patent fit within the global patent landscape?
It may be part of an international patent family aiming to protect similar inventions across jurisdictions, contributing to global patent strategies.
4. What are potential challenges this patent could face?
Prior art in similar chemical classes, limited inventive step, or overlapping with existing patents could threaten its enforceability.
5. What strategic steps should patent holders pursue?
Regular patent landscape analyses, filing of continuation or divisional applications for broader coverage, and monitoring of potential infringing patents are crucial.
References
- Patent RU2019136628 – Full patent document and legal status (Official website of the Federal Service for Intellectual Property, Rospatent).
- WIPO Patent Scope and Patent Landscape Reports for Pharmaceutical Sector.
- Russian Federation Patent Law (Federal Law No. 127-FZ), as amended.
